
Theorem appoints two vice presidents
pharmafile | November 12, 2014 | Appointment | Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing | Angela Weston, Kathryn Bohannon, theorem
Contract research organisation Theorem has named Kathryn Bohannon as vice president of its biopharma development unit, and Angela Weston as VP of business development in Europe and Asia.
Bohannon (pictured) has almost 20 years of pharma R&D experience, including Phase I-IV clinical research, laboratory research and development as well as US and global project management and direct sales and marketing.
Weston takes more than 20 years of experience to Theorem, spanning a broad range of commercial disciplines in the pharma, biotech and medical device industries. She has worked extensively in business development, previously serving as senior vice president for business development at a global clinical contract research organisation.
“These professionals further enhance our capabilities and client services,” says John Potthoff, Theorem president and chief executive. “We have the right experts in place to provide meaningful expertise in key aspects of clinical trials.”






